Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
inscho e
(121 results)?
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease.
Nat Med. 2023 Jul;29(7):1760-1774. doi: 10.1038/s41591-023-02414-4. Epub 2023 Jul 6.
Nat Med. 2023.
PMID: 37414897
Free PMC article.
Impact of the COVID-19 pandemic on recruitment to clinical research studies in rheumatology.
Mirza M, Siebert S, Pratt A, Insch E, McIntosh F, Paton J, Wright C, Buckley CD, Isaacs J, McInnes IB, Raza K, Falahee M.
Mirza M, et al. Among authors: insch e.
Musculoskeletal Care. 2022 Mar;20(1):209-213. doi: 10.1002/msc.1561. Epub 2021 May 3.
Musculoskeletal Care. 2022.
PMID: 33938621
Free PMC article.
No abstract available.
Item in Clipboard
The student patient alliance: development and formative evaluation of an initiative to support collaborations between patient and public involvement partners and doctoral students.
Simons G, Birch R, Stocks J, Insch E, Rijckborst R, Neag G, McColm H, Romaniuk L, Wright C, Phillips BE, Jones SW, Pratt AG, Siebert S, Raza K, Falahee M.
Simons G, et al. Among authors: insch e.
BMC Rheumatol. 2023 Oct 3;7(1):36. doi: 10.1186/s41927-023-00359-2.
BMC Rheumatol. 2023.
PMID: 37789423
Free PMC article.
Item in Clipboard
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.
Goodyear CS, Patel A, Barnes E, Willicombe M, Siebert S, de Silva TI, Snowden JA, Lim SH, Bowden SJ, Billingham L, Richter A, Carroll M, Carr EJ, Beale R, Rea D, Parry H, Pirrie S, Lim Z, Satsangi J, Dunachie SJ, Cook G, Miller P, Basu N, Gilmour A, Hodgkins AM, Evans L, Hughes A, Longet S, Meacham G, Yong KL, A'Hearne MJ, Koh MBC, Burns SO, Orchard K, Paterson C, McIlroy G, Murray SM, Thomson T, Dimitriadis S, Goulston L, Miller S, Keillor V, Prendecki M, Thomas D, Kirkham A, McInnes IB, Kearns P; OCTAVE-DUO investigators.
Goodyear CS, et al.
Lancet Rheumatol. 2024 May 8:S2665-9913(24)00065-1. doi: 10.1016/S2665-9913(24)00065-1. Online ahead of print.
Lancet Rheumatol. 2024.
PMID: 38734019
Free article.
Item in Clipboard
Cite
Cite